Induction and Maintenance Therapy With Infliximab for Children With Moderate to Severe Ulcerative Colitis
Jeffrey S. Hyams(Connecticut Children's Medical Center), Anne M. Griffiths(University of Toronto), Robert N. Baldassano(Children's Hospital of Philadelphia), Lakshmi Damaraju(Janssen (Belgium)), G. Veereman‐Wauters(Semmelweis University), Marion Blank(Janssen (United States)), Cynthia Guzzo(Janssen (Belgium)), Stanley A. Cohen(Troy Gastroenterology), Harland S. Winter(Massachusetts General Hospital), James Markowitz(Philadelphia University), Wallace Crandall, Subra Kugathasan(Children's Healthcare of Atlanta), Jewel Johanns(Janssen (United States)), Johanna C. Escher(Erasmus MC - Sophia Children’s Hospital)
Cited by 282
Related Papers
Human gut microbiome viewed across age and geography
|Nature|2012|7.9k
Linking Long-Term Dietary Patterns with Gut Microbial Enterotypes
|Science|2011|6.6k
The Treatment-Naive Microbiome in New-Onset Crohn’s Disease
|Cell Host & Microbe|2014|3.3k